FRE vs on! PLUS: Synthetic vs FDA-Authorized Pouches
FRE's synthetic nicotine vs on! PLUS's FDA-authorized pouches—regulatory status, strength, flavor, and value compared for users 21+.
TL;DR
on! PLUS Rich Berry 4mg wins for users 21 and older who prioritize FDA authorization and mild strength with regulatory clarity. FRE Watermelon 12mg is the pick for experienced users seeking maximum strength with synthetic nicotine who accept PMTA-pending status. The regulatory divide between these brands is the defining difference.
In one sentence: on! PLUS Rich Berry 4mg offers FDA-authorized assurance at mild strength, while FRE Watermelon 12mg delivers triple the nicotine using synthetic sources without current FDA authorization.
| Brand | Flavor | Strength | Pouches/Can | FDA Status |
|---|---|---|---|---|
| on! PLUS | Rich Berry | 4mg | 20 | FDA Authorized (PMTA) |
| FRE | Watermelon | 12mg | 20 | PMTA Submitted (Not Authorized as of May 2026) |
How We Evaluated
- Regulatory Status: We verified FDA PMTA authorization status through official FDA databases and manufacturer disclosures as of September 2026.
- Nicotine Source: We documented whether each product uses tobacco-derived or synthetic nicotine based on manufacturer specifications.
- Strength Delivery: We compared labeled nicotine content per pouch and assessed appropriateness for different experience levels among adults 21 and older.
- Flavor Profile: We evaluated fruit flavor authenticity, sweetness level, and throat feel during extended use sessions.
- Value Proposition: We analyzed pouches per can, strength-to-price ratio, and the premium associated with FDA authorization status.
on! PLUS Rich Berry 4mg
on! PLUS Rich Berry 4mg is manufactured by Helix Innovations LLC, an Altria subsidiary, and represents one of the FDA-authorized nicotine pouch options available to US consumers 21 and older. The 4mg strength positions this SKU as an entry-level option within the on! PLUS lineup.
Pros:
- FDA Authorized through the PMTA process, providing regulatory assurance
- Tobacco-derived nicotine from a major US manufacturer with established quality controls
- 4mg strength appropriate for new users or those stepping down from higher-strength products
- 20 pouches per can matching industry standard format
Cons:
- Lower strength may not satisfy heavy users or those accustomed to 6mg+ products
- Rich Berry flavor profile is less distinct than single-fruit options
- Premium pricing tier associated with FDA-authorized status
The Rich Berry flavor combines multiple fruit notes rather than highlighting a single variety. According to our evaluation sessions, the berry blend leans toward sweetness with moderate tartness. The 4mg nicotine delivery provides a gentle throat sensation without the intensity of higher-strength options. For professionals 21 and older seeking a discreet, regulated product during work hours, on! PLUS Rich Berry 4mg offers predictable performance with federal marketing authorization.
FRE Watermelon 12mg
FRE Watermelon 12mg is manufactured by Turning Point Brands and uses synthetic nicotine derived from non-tobacco sources. The 12mg strength represents the top tier of FRE's product range and targets experienced users 21 and older who require maximum nicotine delivery.
Pros:
- 12mg strength delivers three times the nicotine of the on! PLUS 4mg comparison product
- Synthetic nicotine appeals to users specifically seeking non-tobacco-derived options
- Watermelon flavor provides distinct, recognizable fruit profile
- 20 pouches per can at typically lower price point than FDA-authorized competitors
Cons:
- PMTA submitted but not yet FDA authorized as of September 2026, creating regulatory uncertainty
- 12mg strength too intense for new users or those sensitive to nicotine effects
- Synthetic nicotine source may not appeal to users who prefer traditional tobacco-derived products
FRE Watermelon 12mg delivers a candy-like watermelon sweetness that some users 21 and older find appealing for all-day use, while others perceive it as overly artificial compared to natural fruit flavors. The 12mg nicotine content produces a pronounced throat sensation and rapid satisfaction for heavy users. However, the lack of FDA marketing authorization as of September 2026 means this product exists in a regulatory gray area that may concern some consumers.
Regulatory Status: The Critical Differentiator
According to FDA documentation current through September 2026, on! PLUS Rich Berry 4mg has received FDA marketing authorization through the Premarket Tobacco Application (PMTA) process. This authorization means the FDA determined that marketing this specific product is appropriate for the protection of public health. on! PLUS joined ZYN as one of the only nicotine pouch brands with authorized SKUs available to US consumers 21 and older.
FRE Watermelon 12mg has submitted a PMTA but has not yet received FDA marketing authorization as of September 2026. Turning Point Brands continues to market the product while the application remains under FDA review. This regulatory status difference represents the single most significant distinction between these brands for consumers who prioritize federal oversight.
The synthetic versus tobacco-derived nicotine question also factors into regulatory considerations. FRE's use of synthetic nicotine initially allowed the brand to avoid certain FDA tobacco regulations, though subsequent legislative changes brought synthetic nicotine products under the same regulatory framework as tobacco-derived products. on! PLUS's tobacco-derived nicotine follows the traditional extraction pathway that has been subject to FDA oversight since the agency gained authority over tobacco products.
Strength Comparison: 4mg vs 12mg
The three-fold strength difference between on! PLUS Rich Berry 4mg and FRE Watermelon 12mg creates distinct use cases. on! PLUS Rich Berry 4mg suits users 21 and older who are new to nicotine pouches, stepping down from higher strengths, or seeking mild nicotine delivery throughout the day without building tolerance. The 4mg level provides satisfaction without overwhelming the palate or producing excessive salivation.
FRE Watermelon 12mg targets experienced users who have built tolerance through regular use of 6mg or 9mg products and require stronger delivery to achieve satisfaction. The 12mg strength produces rapid nicotine absorption and pronounced throat sensation. For users 21 and older accustomed to high-strength snus or heavy cigarette use, FRE Watermelon 12mg offers the intensity needed to replace previous nicotine sources.
Neither strength is inherently superior—appropriateness depends entirely on individual tolerance and nicotine requirements. However, the lack of mid-range options in this specific comparison (no 6mg or 9mg variants included) means these two products serve fundamentally different user populations.
Flavor Profile Analysis
on! PLUS Rich Berry 4mg combines multiple berry notes into a unified profile. The flavor opens with initial sweetness, followed by subtle tartness, and maintains consistency throughout the 20-30 minute use window typical for 4mg pouches. The berry blend avoids the single-note intensity of strawberry or raspberry-only flavors, creating a more generalized fruit experience.
FRE Watermelon 12mg delivers immediately recognizable watermelon candy sweetness. According to evaluator feedback from users 21 and older, the flavor profile resembles watermelon hard candy more than fresh fruit. The sweetness level remains high throughout use, which some experienced users appreciate for masking the stronger nicotine sensation, while others find it cloying during extended sessions.
For users who prefer authentic fruit flavors, neither option perfectly replicates fresh berry or watermelon taste. Both lean toward candy-style sweetness, though on! PLUS Rich Berry maintains slightly more complexity through its multi-berry approach.
Value and Format Comparison
Both FRE Watermelon 12mg and on! PLUS Rich Berry 4mg contain 20 pouches per can, matching the industry standard format used by VELO, Rogue, and other major brands. This standardization allows direct cost-per-pouch comparison without format adjustment calculations.
on! PLUS Rich Berry 4mg typically commands premium pricing associated with FDA-authorized products. The regulatory investment required to achieve PMTA approval translates to higher retail costs that some users 21 and older willingly pay for federal marketing authorization assurance.
FRE Watermelon 12mg generally offers more competitive pricing in the PMTA-pending category. The synthetic nicotine formulation and Turning Point Brands' manufacturing scale support mid-tier pricing that delivers better per-milligram nicotine value for budget-conscious users.
When calculating value, users must weigh regulatory status, strength requirements, and absolute cost. A lower-priced 12mg product may seem economical, but users who only need 4mg strength will waste nicotine and potentially build unwanted tolerance. Conversely, paying premium prices for FDA authorization provides no functional benefit if regulatory status is not a personal priority.
Pouch Comfort and Discretion
Both brands use slim-format pouches designed for upper-lip placement. on! PLUS Rich Berry 4mg pouches feature soft, fleece-like material that conforms to the gum line with minimal shifting during speech or movement. The 4mg strength produces light salivation, making the pouch comfortable for extended wear among professionals 21 and older in workplace settings.
FRE Watermelon 12mg pouches use similar slim construction with slightly firmer packing to accommodate the higher nicotine content. The 12mg strength generates more pronounced salivation and throat sensation, which some users interpret as confirmation of nicotine delivery, while others find it distracting during meetings or focused work.
For maximum discretion in professional environments, the lower strength and milder physical sensation of on! PLUS Rich Berry 4mg provides advantages. For personal use where sensation intensity is desired, FRE Watermelon 12mg delivers more noticeable effects.
Which One Should You Actually Buy?
Choose on! PLUS Rich Berry 4mg if you are an adult 21 or older who prioritizes FDA marketing authorization above all other factors. The regulatory clarity of a PMTA-approved product provides assurance that cannot be matched by pending-status brands, regardless of price or strength. This option also suits new users, those stepping down from higher strengths, or anyone requiring mild, consistent nicotine delivery throughout the day in professional settings. The tobacco-derived nicotine source appeals to users who prefer traditional extraction methods over synthetic alternatives.
Choose FRE Watermelon 12mg if you are an experienced user 21 or older who requires maximum strength delivery and accepts PMTA-pending regulatory status as a calculated trade-off for lower pricing and synthetic nicotine sourcing. The 12mg strength serves heavy users who find 4mg or 6mg products inadequate for satisfaction. The watermelon candy flavor profile works for users who enjoy sweet, fruit-forward profiles and do not prioritize authentic fresh-fruit taste.
If regulatory status is your primary concern, on! PLUS Rich Berry 4mg is the only choice between these two products with current FDA authorization. If maximum nicotine strength is non-negotiable and you accept pending PMTA status, FRE Watermelon 12mg is the clear pick. For users who need middle-ground strength (6mg or 9mg), neither of these specific SKUs is optimal—consider other on! PLUS variants at 6mg or 9mg strength, which also carry FDA authorization, or mid-range FRE options at 6mg or 9mg if synthetic nicotine is preferred despite pending PMTA status.
The $8+ price gap per can between budget synthetic brands and FDA-authorized options represents real money for daily users. Calculate your monthly cost at your typical consumption rate before committing to either brand. A single can every three days means 10 cans monthly—premium pricing adds $80+ annually compared to budget options. Decide whether FDA authorization justifies that premium for your personal priorities as an adult 21 or older making informed choices about nicotine products.